Business Description
Teh Seng Pharmaceutical Mfg Co Ltd
ISIN : TW0007860009
Description
Teh Seng Pharmaceutical Mfg Co Ltd is engaged in the development and manufacturing of various pain relieving patches, cosmetic patches and biotechnology products. Its products include: Hydrogel Patches, Oil-Based Patches, Hot-Melt Patches, CMO & CRO for Transdermal Patch, Oral Film & Sublingual, Cosmetic Patches, Biotechnology Products and Daily Supplements.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.01 | |||||
Equity-to-Asset | 0.79 | |||||
Debt-to-Equity | 0.12 | |||||
Debt-to-EBITDA | 0.77 | |||||
Interest Coverage | 66.19 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 7.18 | |||||
Beneish M-Score | -0.79 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 99.92 | |||||
9-Day RSI | 98.44 | |||||
14-Day RSI | 94.09 | |||||
3-1 Month Momentum % | -2.93 | |||||
6-1 Month Momentum % | -13.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.47 | |||||
Quick Ratio | 1.91 | |||||
Cash Ratio | 1.44 | |||||
Days Inventory | 100.62 | |||||
Days Sales Outstanding | 44.58 | |||||
Days Payable | 21.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 3.68 | |||||
Forward Dividend Yield % | 3.68 | |||||
5-Year Yield-on-Cost % | 3.68 | |||||
Shareholder Yield % | 4.49 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 27.47 | |||||
Operating Margin % | 16.65 | |||||
Net Margin % | 12.19 | |||||
EBITDA Margin % | 20.78 | |||||
FCF Margin % | 10.84 | |||||
OCF Margin % | 12.91 | |||||
ROE % | 9.57 | |||||
ROA % | 7.12 | |||||
ROIC % | 11.45 | |||||
ROC (Joel Greenblatt) % | 17.99 | |||||
ROCE % | 12.59 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 25.39 | |||||
PE Ratio without NRI | 25.39 | |||||
PS Ratio | 3.1 | |||||
PB Ratio | 2.34 | |||||
Price-to-Tangible-Book | 2.34 | |||||
Price-to-Free-Cash-Flow | 28.57 | |||||
Price-to-Operating-Cash-Flow | 24 | |||||
EV-to-EBIT | 17.08 | |||||
EV-to-EBITDA | 13.3 | |||||
EV-to-Revenue | 2.76 | |||||
EV-to-FCF | 25.49 | |||||
Price-to-Graham-Number | 1.62 | |||||
| Price-to-Net-Current-Asset-Value | 6.37 | |||||
| Price-to-Net-Cash | 22.03 | |||||
Earnings Yield (Greenblatt) % | 5.85 | |||||
FCF Yield % | 3.51 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Teh Seng Pharmaceutical Mfg Co Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 845.192 | ||
| EPS (TTM) (NT$) | 3.21 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 94.09 | ||
| 14-Day ATR (NT$) | 1.802467 | ||
| 20-Day SMA (NT$) | 68.83 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (NT$) | 53.3 - 102 | ||
| Shares Outstanding (Mil) | 32 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Teh Seng Pharmaceutical Mfg Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Teh Seng Pharmaceutical Mfg Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 3.000000 Cash Dividend | 2026-04-23 | 63.00 (-2.78%) |
Show
Entries
Teh Seng Pharmaceutical Mfg Co Ltd Frequently Asked Questions
What is Teh Seng Pharmaceutical Mfg Co Ltd(ROCO:7860)'s stock price today?
The current price of ROCO:7860 is NT$81.50. The 52 week high of ROCO:7860 is NT$102.00 and 52 week low is NT$53.30.
When is next earnings date of Teh Seng Pharmaceutical Mfg Co Ltd(ROCO:7860)?
The next earnings date of Teh Seng Pharmaceutical Mfg Co Ltd(ROCO:7860) is .
Does Teh Seng Pharmaceutical Mfg Co Ltd(ROCO:7860) pay dividends? If so, how much?
The Dividend Yield %  of Teh Seng Pharmaceutical Mfg Co Ltd(ROCO:7860) is 3.68% (As of Today), Highest Dividend Payout Ratio of Teh Seng Pharmaceutical Mfg Co Ltd(ROCO:7860) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Teh Seng Pharmaceutical Mfg Co Ltd(ROCO:7860) is 3.68%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Teh Seng Pharmaceutical Mfg Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers